Torchilin V - Search Results

1

Antibody-modified liposomes for cancer chemotherapy.

Torchilin V. Torchilin V. Expert Opin Drug Deliv. 2008 Sep;5(9):1003-25. doi: 10.1517/17425247.5.9.1003. Expert Opin Drug Deliv. 2008. PMID: 18754750 Review.

2

Liposomes for targeted delivery of antithrombotic drugs.

Elbayoumi TA, Torchilin VP. Elbayoumi TA, et al. Expert Opin Drug Deliv. 2008 Nov;5(11):1185-98. doi: 10.1517/17425240802497457. Expert Opin Drug Deliv. 2008. PMID: 18976130 Review.

3

Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.

Deshpande P, Jhaveri A, Pattni B, Biswas S, Torchilin V. Deshpande P, et al. Among authors: torchilin v. Drug Deliv. 2018 Nov;25(1):517-532. doi: 10.1080/10717544.2018.1435747. Drug Deliv. 2018. PMID: 29433357 Free PMC article.

4

Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro.

Sawant RM, Cohen MB, Torchilin VP, Rokhlin OW. Sawant RM, et al. J Drug Target. 2008 Aug;16(7):601-4. doi: 10.1080/10611860802228954. J Drug Target. 2008. PMID: 18686131

5

Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers.

Mendes LP, Sarisozen C, Luther E, Pan J, Torchilin VP. Mendes LP, et al. Drug Deliv. 2019 Dec;26(1):443-458. doi: 10.1080/10717544.2019.1574935. Drug Deliv. 2019. PMID: 30929529 Free PMC article.

6

Liposomes for cardiovascular targeting.

Levchenko TS, Hartner WC, Torchilin VP. Levchenko TS, et al. Ther Deliv. 2012 Apr;3(4):501-14. doi: 10.4155/tde.12.18. Ther Deliv. 2012. PMID: 22834079 Review.

7

Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.

Gupta B, Torchilin VP. Gupta B, et al. Cancer Immunol Immunother. 2007 Aug;56(8):1215-23. doi: 10.1007/s00262-006-0273-0. Epub 2007 Jan 12. Cancer Immunol Immunother. 2007. PMID: 17219149 Free PMC article.

8

Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents.

Elbayoumi TA, Pabba S, Roby A, Torchilin VP. Elbayoumi TA, et al. J Liposome Res. 2007;17(1):1-14. doi: 10.1080/08982100601186474. J Liposome Res. 2007. PMID: 17454399

9

Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody.

Lukyanov AN, Elbayoumi TA, Chakilam AR, Torchilin VP. Lukyanov AN, et al. J Control Release. 2004 Nov 5;100(1):135-44. doi: 10.1016/j.jconrel.2004.08.007. J Control Release. 2004. PMID: 15491817

10

Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate.

Torchilin VP. Torchilin VP. Adv Drug Deliv Rev. 2005 Jan 2;57(1):95-109. doi: 10.1016/j.addr.2004.06.002. Adv Drug Deliv Rev. 2005. PMID: 15518923 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters